DBV Technologies raises up to $306.9M via private placement for Viaskin Peanut BLA

DBV Technologies S.A.

Gross proceeds up to $306.9M: $125.5M upfront plus up to $181.4M if all warrants exercised.
Immediate dilution of 22.4%; maximum dilution of 73.7% if all warrants exercised.
Existing cash only sufficient into April 2025; with upfront proceeds, cash runway extended to June 2026.
VITESSE Phase 3 results expected Q4 2025; warrant exercise period accelerates if primary endpoint met.
Proceeds to fund BLA submission and commercial launch readiness for Viaskin Peanut in 4-7 year olds.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.